MedTech Solutions S.A. (WSE:MDT)
0.7150
-0.0300 (-4.03%)
At close: Jun 15, 2026
MedTech Solutions Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.38 | 2.01 | 1.61 | 0.06 | 1.16 | |
Revenue Growth (YoY) | -81.16% | 24.33% | 2707.57% | -95.02% | 138.64% |
Cost of Revenue | 0.28 | 1.36 | 1.19 | 0.01 | 0.92 |
Gross Profit | 0.1 | 0.65 | 0.42 | 0.05 | 0.24 |
Selling, General & Admin | 2.89 | 1.72 | 1.05 | 0.29 | 0.95 |
Other Operating Expenses | 0.33 | 0.08 | 0.03 | -0 | 0.22 |
Operating Expenses | 3.32 | 1.85 | 1.11 | 0.29 | 1.61 |
Operating Income | -3.22 | -1.2 | -0.69 | -0.23 | -1.37 |
Interest Expense | - | -0.08 | -0.01 | -0 | -0.57 |
Interest & Investment Income | -0.08 | 0 | 0 | 0.01 | 0.5 |
Currency Exchange Gain (Loss) | - | - | - | - | 1.13 |
Other Non Operating Income (Expenses) | -0.03 | 0 | -0 | -0 | -1.46 |
EBT Excluding Unusual Items | -3.33 | -1.28 | -0.69 | -0.23 | -1.77 |
Gain (Loss) on Sale of Investments | -0 | -0.05 | -0.11 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | 6.9 |
Pretax Income | -3.33 | -1.33 | -0.8 | -0.23 | 5.14 |
Income Tax Expense | - | 0 | -0 | -0 | 1.32 |
Earnings From Continuing Operations | -3.33 | -1.34 | -0.8 | -0.23 | 3.82 |
Minority Interest in Earnings | - | - | - | - | -1.23 |
Net Income | -3.33 | -1.34 | -0.8 | -0.23 | 2.6 |
Net Income to Common | -3.33 | -1.34 | -0.8 | -0.23 | 2.6 |
Shares Outstanding (Basic) | - | 10 | 10 | 9 | 9 |
Shares Outstanding (Diluted) | - | 10 | 10 | 9 | 9 |
Shares Change (YoY) | - | -0.43% | 16.52% | -0.11% | - |
EPS (Basic) | - | -0.13 | -0.08 | -0.03 | 0.30 |
EPS (Diluted) | - | -0.13 | -0.08 | -0.03 | 0.30 |
Free Cash Flow | -3.94 | -1.06 | -1.04 | -0.4 | 0.47 |
Free Cash Flow Per Share | - | -0.11 | -0.10 | -0.05 | 0.05 |
Gross Margin | 25.73% | 32.17% | 26.08% | 89.36% | 20.52% |
Operating Margin | -851.36% | -59.83% | -42.68% | -407.18% | -118.44% |
Profit Margin | -880.39% | -66.56% | -49.64% | -398.72% | 224.68% |
Free Cash Flow Margin | -1042.61% | -52.83% | -64.51% | -686.98% | 40.35% |
EBITDA | -3.13 | -1.16 | -0.66 | 0.13 | -1.01 |
EBITDA Margin | - | -57.84% | -40.82% | 222.39% | -87.10% |
D&A For EBITDA | 0.09 | 0.04 | 0.03 | 0.36 | 0.36 |
EBIT | -3.22 | -1.2 | -0.69 | -0.23 | -1.37 |
EBIT Margin | - | -59.83% | -42.68% | - | -118.44% |
Effective Tax Rate | - | - | - | - | 25.59% |
Revenue as Reported | 0.36 | 2.01 | 1.61 | 0.06 | - |